Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTR.L Regulatory News (WTR)

  • There is currently no data for WTR

Interim Management Statement

3 Feb 2016 12:21

RNS Number : 9630N
World Trust Fund (The)
03 February 2016
 

The World Trust Fund

Interim Management Statement

 for the quarter ended 31st December 2015

 

The World Trust Fund (the "Fund") is publishing this Interim Management Statement in accordance with the Luxembourg law of 11 January 2008 on Transparency requirements (the "Transparency law").

 

This Interim Management Statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the Transparency law. It should not be relied upon by any other party or for any other purpose.

 

This Interim Management Statement relates to the period from 1 October 2015 to 31 December 2015 and contains information that covers this period and the period up to the date of publication of this Interim Management Statement.

 

The Fund aims to achieve long-term capital appreciation by investing in companies, in the main closed-end investment companies, whose shares trade at a discount to their underlying net asset value and are listed on international exchanges. For hedging purposes the Fund may also sell short stock indices, stocks, and shares of exchange-traded funds or closed-end funds, not exceeding 100% of the Fund's net assets.

 

Highlights:

Over the 3 month period from 1 October 2015 to 31 December 2015:

 

· The Fund's diluted net asset value (NAV) rose 7.5% to $4.376 in US$ terms (base currency), compared with a rise of 5.0% in the MSCI All Countries World Index.

· The Fund's share price rose in Sterling terms by 8.9% to 252 pence.

· The discount to NAV (in Sterling) at the end of the period was -15.1%.

· The Fund's underlying holdings had an average weighted discount of -22.5%.

 

 

Long Term Performance:

 

1-Year

3-Year**

5-Year**

10-Year**

Share Price £

+3.8%

+9.1%

+5.1%

+1.7%

Share Price US$*

-1.8%

+5.6%

+4.0%

+0.2%

Net Asset Value £*

+6.6%

+11.0%

+6.5%

+2.6%

Net Asset Value US$

+0.7%

+7.5%

+5.3%

+1.0%

MSCI All Countries World US$

-2.4%

+7.7%

+6.1%

+4.8%

MSCI AC World Ex USA

-5.7%

+1.5%

+1.1%

+2.9%

 

The MSCI All Countries World index is shown solely for the purpose of performance comparison, and in no way reflects the composition of the portfolio.

*Converted using Foreign Exchange rate used by the administrator.

** Annualized.

Top Five Holdings (%):

31/12/15

30/09/15

BB Biotech

7.2%

6.9%

Eurazeo

5.7%

5.8%

JPMorgan European Smaller Companies

5.4%

5.0%

General American Investors

5.4%

5.7%

Investor AB

4.7%

4.7%

 

 

 

 

 

Top 5 Regional Breakdown (%)

31/12/15

30/09/15

North America

23.0%

29.2%

Asia (ex-Japan)

25.1%

27.6%

Europe (ex-UK)

21.2%

21.6%

United Kingdom

10.8%

9.6%

Japan

9.5%

9.2%

 

 

31/12/15

30/09/15

Long Exposure

98.8%

101.0%

Short Exposure

0%

0.0%

Net Exposure

98.8%

101.0%

 

 

Top 10 Country Weightings (%)

 

31/12/15

United States

22.7

China

12.9

United Kingdom

10.8

Japan

9.5

France

5.7

Sweden

4.8

Switzerland

3.8

India

2.9

Philippines

2.3

Hong Kong

2.0

 

 

Leverage:

As at 31 December 2015 the Fund had no leverage.

 

Material Transactions and Events:

 

Since the period end the Fund paid a dividend of 1.0p per share on 15 January 2016 to its shareholders who appeared on its register on 18 December 2015.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFLFFTIVIIR
Date   Source Headline
2nd Oct 20189:28 amBUSNet Asset Value(s)
1st Oct 20189:01 amBUSNet Asset Value(s)
28th Sep 201810:58 amBUSNet Asset Value(s)
27th Sep 201810:19 amBUSNet Asset Value(s)
26th Sep 20189:53 amBUSNet Asset Value(s)
25th Sep 201810:05 amBUSNet Asset Value(s)
24th Sep 201812:07 pmBUSNet Asset Value(s)
21st Sep 20189:40 amBUSNet Asset Value(s)
20th Sep 20183:53 pmRNSResult of AGM
20th Sep 201810:25 amBUSNet Asset Value(s)
19th Sep 20189:39 amBUSNet Asset Value(s)
18th Sep 20189:56 amBUSNet Asset Value(s)
17th Sep 201810:34 amBUSNet Asset Value(s)
14th Sep 201812:12 pmBUSNet Asset Value(s)
12th Sep 201812:00 pmRNSJuly 2018 Fact Sheet
5th Sep 201812:42 pmRNSReplacement Holding(s) in Company
5th Sep 201811:27 amRNSHolding(s) in Company
31st Aug 20185:04 pmRNSHolding(s) in Company
30th Aug 20182:51 pmRNSResult of Extraordinary General Meeting
30th Aug 201811:23 amRNSTransaction in Own Shares
24th Aug 20187:00 amRNSTransaction in Own Shares
21st Aug 20187:00 amRNSTransaction in Own Shares
20th Aug 20187:00 amRNSHolding(s) in Company
17th Aug 201811:28 amRNSHolding(s) in Company
15th Aug 201810:54 amRNSEGM and discount management policy
10th Aug 201811:13 amRNSHolding(s) in Company
9th Aug 20183:40 pmRNSPublication of Circular
8th Aug 20187:00 amRNSTransaction in Own Shares
1st Aug 20185:14 pmRNSTotal Voting Rights
1st Aug 201810:57 amRNSJune 2018 Fact Sheet
30th Jul 20187:00 amRNSDividend Declaration
30th Jul 20187:00 amRNSFinal Results
27th Jul 20187:00 amRNSTransaction in Own Shares
26th Jul 20187:00 amRNSTransaction in Own Shares
25th Jul 20187:00 amRNSTransaction in Own Shares
23rd Jul 20189:30 amBUSNet Asset Value(s)
20th Jul 201810:39 amBUSNet Asset Value(s)
19th Jul 20189:18 amBUSNet Asset Value(s)
18th Jul 201812:07 pmBUSNet Asset Value(s)
18th Jul 20187:00 amRNSTransaction in Own Shares
17th Jul 20189:44 amBUSNet Asset Value(s)
16th Jul 201812:45 pmBUSNet Asset Value(s)
13th Jul 201810:17 amBUSNet Asset Value(s)
12th Jul 20189:18 amBUSNet Asset Value(s)
12th Jul 20187:00 amRNSTransaction in Own Shares
11th Jul 201811:03 amBUSNet Asset Value(s)
11th Jul 20187:00 amRNSTransaction in Own Shares
10th Jul 20189:43 amBUSNet Asset Value(s)
9th Jul 20183:34 pmBUSNet Asset Value(s)
9th Jul 20187:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.